An APA and SAMHSA Initiative

Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Person-First Language
Our Apps
SMI Adviser App My Mental Health Crisis Plan
About Us
Calendar
Contact

Search for:

∕
Knowledge Base
∕
Co-morbid Substance Use Disorders

Topic: Co-morbid Substance Use Disorders

Knowledge Base (Clinicians)

94 result(s) found.

What are the best ways of helping people with serious mental illnesses quit tobacco?
If marijuana is legal, is it ok for patients with serious mental illness to use it?
What are smoking cessation tools for those with schizophrenia?
Is substance abuse common in people with schizophrenia?
Can effective peer support be provided for individuals with co-occurring mental health and substance use disorders?
Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care
Position Statement 33: Substance Use Disorders
Are there smoking cessation treatments that are effective in patients with serious mental illness (SMI)?
What is the best practice for treatment of co-occurring disorders?
Substance Use Best Practice Tool Guide
What are the challenges of patients accepting medication assisted treatment (MAT) for their opiate use disorder?
Issue Brief: Substance-Induced Psychosis in First Episode Programming
Medication-Assisted Treatment (MAT) in the Criminal Justice System: Brief Guidance to the States
What are available practice guidelines for substance abuse disorder?
What should primary care providers know how to do if they are working in mental health setting?
Is there a healthcare model that can treat medical problems, mental health conditions and substance use disorders at the same time and place?
What’s the best way to deal with a young person who is struggling with BOTH a substance use disorder and a psychiatric illness?
How does opioid use disorder increase the risk of contracting Hepatitis C and HIV?
Is it possible to receive primary care inside an opiate treatment program?
How do you manage Substance Use Disorders (SUDs) when the patient is also exhibiting signs of non SUD psychiatric disorders such as depression, bipolar, psychosis, PTSD or ADHD?
How do you optimize the clinical management of persons opioid use disorders (OUD) and co-occurring psychiatric disorders who are actively using opioids and are experiencing significant pain?
How do primary care providers and mental health experts feel about opioid and benzodiazepines co-prescribing?
How are Opioid Use Disorders (OUD) related to non-OUD psychiatric disorders?
How to screen and assess SUD in adolescents?
What role do primary care providers play in the evaluation of problematic substance use?
In lethal opioid overdoses, how do you differentiate between suicide by overdose and “accidental” overdoses?
How can Community Behavioral Health Organizations (CBHOs) help improve access to MAT for opioid use disorders?
What are best practices for managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder and what are the risks associated with it?
What are best practices for managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder and what are the risks associated with it?
There is a known association between depression and pain but is there also a connection between bipolar disorder and pain?
How do I get insurance to cover mental health and substance use disorder treatment?
Decisions in Recovery: Treatment for Opioid Use Disorder
Substance Use Disorders
How does the collaborative care model improve treatment access for people with substance use disorders?
For patients on MAT, how can behavioral treatment protocols be effective in supporting recovery?
If patients with opioid use disorders are detoxified successfully, why should they take medications rather than remaining “completely abstinent”?
For patients with opioid use disorder, why use medications such as methadone or buprenorphine that are themselves opioids?
How to address patient resistance to taking medications for the treatment of their addictions?
How should doctors and their patients decide on the most appropriate pharmacological treatment with opioid use disorder?
What treatment options are available to persons with opioid use disorder and co-occurring pain?
What are the implications of the SAMHSA final rule to increase the Buprenorphine patient limit to 275?
What can be done to address stigma in addictions?
What interventions address stigma in addictions?
How can psychosocial interventions contribute to improving medication assisted treatment outcomes in patients with SUD?
What interventions are found to be effective in supporting treatment and recovery for adolescents with substance use disorders?
What is the FDA doing to address the opioid crisis?
How should urine drug testing be used in clinical practice?
What are the office procedures that should be followed when prescribing buprenorphine?
Why should urine drug screening be done in clinical practice?
What are four things that can be done to address the opioid epidemic?
How can telepsychiatry be used to treat addictive disorders?
What is Smart Recovery and isn’t it the same as AA?
How can healthcare providers prevent acute pain from becoming chronic pain?
What support options are available for healthcare providers with substance use disorders?
What are the components of a self-management approach to chronic pain?
How can communities address the barriers for potential outpatient buprenorphine prescribers in order to encourage them to treat patients with opioid use disorder?
Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment: A Treatment Improvement Protocol (TIP) Series 50
How can clinicians assist patients with serious mental illness implement smoking cessation with evidence-based practices?
Coexisting severe mental illness and substance misuse: community health and social care services
Can people with serious mental illness quit smoking tobacco, and what treatments, including medications, can help with this?
Kansas Tobacco Guideline for Behavioral Heath Care: An Implementation Toolkit
Implementing Tobacco-Free Policies in Community Behavioral Health Organizations
Saving Lives: What You Can Do To Help Reduce Tobacco Use in Community Mental Health Settings
What is the evidence for cannabinoids for the treatment of SMI and symptoms of SMI?
HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
Smoking Cessation Interventions with Behavioral Health Populations
Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
Implementing Tobacco Cessation Treatment for Individuals with Serious Mental Illness: A Quick Guide for Program Directors and Clinicians
What are the statistics regarding mental health and substance use issues of individuals experiencing homelessness?
Clinical Guide for Integrated Dual Disorder Treatment (IDDT)
Is there cause to be concerned about smoking among people with mental illness?
What resources are available to raise awareness of individuals, caregivers and the community about the dangers of smoking and mental illness?
What tobacco cessation products are covered under Medicaid?
What should clinicians know about prescribing (naltrexone) Vivitrol injections for patients with co-occuring alcohol use disorder?
Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis
Implementing Tobacco Cessation Programs in Substance Use Disorder Treatment Settings
Adult Smoking: Focusing on People with Mental Illness
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial
Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness
Integrated Systems and Services for People with Co-Occurring Mental Health and Substance Use Conditions: What’s Known, What’s New, and What’s Now?
Developing a Behavioral Health Workforce Equipped to Serve Individuals with Co-Occurring Mental Health and Substance Use Disorders
Implementation Guide: Serious Mental Illness (SMI) and Co-Occurring Disorders (COD)
Implementation Guide: Integrated screening and longitudinal, strength-based assessment for individuals with serious mental illness (SMI) and co-occurring substance use
Implementation Guide: Integrated Medications for Addiction Treatment (MAT) for Opioid Use Disorder (OUD) in a Serious Mental Illness (SMI) Service Setting
Many of the clients I am referred for assessment in the MH clinic have current or recent substance use. I have been taught that to make a diagnostic assessment, patients need to be substance free for at least thirty days. Yet to provide services, a MH diagnosis is necessary. What should I do?
My MH agency offers a dual diagnosis group, but most of my clients won’t go. How can I help them with their co-occurring substance use if they won’t attend group? Isn’t group treatment the treatment of choice for people with a substance use disorder (SUD)?
How do I help someone who can’t seem to stop using? I’ve been working with a client with SMI and SUD for 3 years. When I met him, he had very severe substance use, but over the years I’ve helped him get into various types of SUD treatment and he has had some periods of sobriety. He keeps telling me he wants to be sober, and he does okay for a while and then he slips. He seems to be a chronic relapser, and I don’t know how to help him.
How do I help clients with psychotic illnesses who report that marijuana (or other substance) is “helpful” or “relaxing”? My client with schizophrenia smokes marijuana whenever he can get it. He says it “relaxes him.” I’m convinced it’s contributing to his continuing psychotic symptoms, and to the fact that his medication doesn’t seem to be effective. He agrees that “many people think marijuana is bad,” but he states: “I’m going to hear voices anyway, and the marijuana helps me to deal with them.” He seems to be in pre-contemplation, and I don’t know what to do.
In my clinic, I am referred SMI patients to initiate or continue psychotropic medications. It is common for patients to be referred who are actively using alcohol, marijuana, and sometimes other substances. What should I do?
How many individuals who have serious mental illness also have a substance use disorder?
Are there treatment plans that can address both SMI and any substance use or co-occurring disorders at the same time?
Is it possible to help individuals who have SMI to quit smoking?
The Stigma of Addiction
Interventions for Substance Use Disorders in Adolescents

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts

Administered by

Funded by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2023 American Psychiatric Association. All rights reserved.

X

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset